1. Introduction {#s0005}
===============

Major depressive disorder (MDD) and bipolar disorder (BD) are common, severe affective diseases that affect people throughout the world ([@bb0130]; [@bb0225]). Because of the high prevalence of depressive symptoms and the similarity to MDD, BD patients are difficult to diagnose correctly in clinical practice ([@bb0140]). Only 20% of BD patients with a depressive episode are diagnosed accurately within the first year of seeking treatment ([@bb0175]) and the mean delay is about 5--10 years from onset to correct diagnosis ([@bb0020]). These misdiagnoses lead to inappropriate treatment and devastating consequences for BD patients ([@bb0260]). Fortunately, the development of neuroimaging techniques has provided opportunities to deepen our knowledge of the mechanisms underpinning affective disorders.

Neuroimaging methods have been widely adopted to study brain structural and functional alterations in affective disorders. Several studies that used voxel-based morphometry (VBM) approach have revealed abnormal gray matter volume (GMV) in MDD in various regions involved in emotion processing, such as the prefrontal cortex (PFC) ([@bb0295]), anterior cingulate cortex (ACC) ([@bb0220]), hippocampus ([@bb0440]), and amygdala ([@bb0110]). In BD patients, abnormal GM has been reported primarily in the PFC ([@bb0125]), ACC ([@bb0030]), and temporal regions ([@bb0315]). We noticed that most of the previous studies focused on the difference in GMV between the patients and healthy subjects, but very few studies ([@bb0280]; [@bb0060]) directly compared the MDD and BD patients from a structural perspective. [@bb0280] detected decreased GMV in the ACC, hippocampus, and amygdala, while [@bb0060] observed increased GMV in the dorsolateral prefrontal cortex (DLPFC), in BD patients compared with MDD patients.

Functional neuroimaging methods have also been used to study brain functional abnormality in BD and MDD patients. Dysfunction in BD or MDD patients has been detected based on resting-state fMRI (R-fMRI) ([@bb0035]; [@bb0435]) and task-fMRI (T-fMRI) techniques ([@bb0095]; [@bb0355]). Several previous studies ([@bb0160]; [@bb0350]; [@bb0285]) reported abnormal functional activation in both MDD and BD patients in the frontal-limbic system, which is believed to support emotion processing and regulation (e.g., ACC and amygdala), reward processing (e.g., OFC and striatum), and cognitive control (e.g., DLPFC and VLPFC). However, the results from the very few studies that have used fMRI to directly compare the brain activity of MDD with that of BD patients have not always been consistent. For instance, [@bb0420] found increased fractional amplitude of low-frequency fluctuations (fALFF) in the SFG and putamen, whereas [@bb0400] detected lower fALFF in the MFG, MTG, and MOG in BD compared with MDD patients. Regarding emotion processing, [@bb0100] observed lower amygdala activation, while [@bb0145] found greater amygdala activation when responding to negative facial stimuli in BD patients compared with MDD patients.

Multimodal techniques that combine structural and functional methods may provide even more useful information for clinical diagnosis. For example, by combining cortical thickness and functional connectivity (FC) analyses in MDD patients, [@bb0330] found indications that PFC thinning may impair the engagement of the ACC during depressive episodes, and [@bb0360] found that cortical thickness of the dmPFC could be used to predict the RSFC between the dmPFC and the default mode network (e.g., the precuneus). The combination of VBM and FC also has been adopted to study schizophrenia ([@bb0415]), temporal lobe epilepsy ([@bb0075]), and Parkinson\'s disease ([@bb0040]). Until now, as far as we know, no prior study has investigated the brain abnormalities in BD or MDD patients by combining VBM and FC analyses.

Our goal in this study was to detect common and distinct brain structural and functional alterations between patients with BD and MDD based on brain structural and functional images. Because medication use and different subtypes of patients can confound the findings, all the patients recruited in the present study were unmedicated and the individuals with BD were type II. In the calculations, we first determined the areas with abnormal GMV and then estimated their resting-state functional connectivity (RSFC) with each voxel throughout the whole brain. Based on the structural and functional abnormalities reported in a previous study ([@bb0045]), we hypothesized that the altered regions in BD and MDD would be primarily located in the prefrontal and limbic areas involving in emotional processing.

2. Methods {#s0010}
==========

2.1. Subjects {#s0015}
-------------

A total of 79 unmedicated, currently depressed patients (18--50 years old), including 36 MDD patients (17 M/26F, 27.9 ± 9.1 years old) and 43 BD II patients (20 M/16F, 30.5 ± 8.5 years old), were recruited from the Psychiatry Department of the First Affiliated Hospital of Jinan University (JNU), Guangzhou, China, from November 2013 to October 2016. The diagnoses of BD and MDD were made by two experienced psychiatrists (Y.J. and S.Z.) according to the Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P). For each patient, the clinical symptoms were assessed according to the 24-item Hamilton Depression Rating Scale (HDRS) ([@bb0375]) and the Young Mania Rating Scale (YMRS) ([@bb0395]) during the 7-day period before the scanning. The inclusion criteria for the MDD patients were a total HDRS score \> 21, while for the BD patients they were a total YMRS score \< 7 and a total HDRS score \> 21. In this study, we excluded patients with (1) any other Axis-I psychiatric disorders or (2) a history of organic brain disorders, neurological disorders, mental retardation, cardiovascular diseases, alcohol/substance abuse, pregnancy, or any physical illness. None of the patients had ever received electroconvulsive therapy prior to participating in the study. All of the patients were either medication-naïve or not medicated for at least 6 months at the time of the scanning. Twenty-nine patients (18 MDD and 11 BD) were medication naïve because they had never been diagnosed before or did not want to take medication. While for the other recruited patients, they generally visited their physicians (psychiatrist/general practitioner) because of depressive relapse after quitting medication. Among them, 18 patients with MDD had been treated with antidepressants (duloxetine or paroxetine), while 32 patients with BD had been treated with antidepressants (duloxetine or paroxetine) and/or mood stabilizers (lithium, sodium valproate) and/or atypical antipsychotic medications (olanzapine or risperidone). For these fifty patients, they had been off-medication for at least 6 months prior to the scan and were therefore currently unmedicated.

In addition, we also recruited 47 age- and gender-matched healthy subjects (22 M/25F, 29.7 ± 9.2 years old) as the control group. The healthy controls (HC) were included if they: (1) were 18--50 years old, (2) fulfilled the diagnostic criteria of the Structured Clinical Interview for DSM-IV non-patient Edition (SCID-NP), (3) were without any current or past significant medical or neurological illness, and (4) were without a history of psychiatric illness in his/her first-degree relatives.

All subjects included in this study were right-handed according to the Edinburgh Handedness Inventory ([@bb0250]). The study was approved by the Ethics Committee of the First Affiliated Hospital of JNU. Each subject provided written consent for participation after a full written and verbal explanation of the study.

2.2. Image acquisition {#s0020}
----------------------

All the subjects were scanned on a 3.0 T GE Discovery MR750 scanner (General Electric, Boston, MA, USA) with an eight-channel phased-array head coil in the Medical Imaging Department of the First Affiliated Hospital of JNU. High resolution brain structural images were obtained with a T1-weighted 3D Ax FSPGR BRAVO sequence. The sequence parameters were as follows: repetition time (TR) = 8.2 ms, echo time (TE) = 3.2 ms, flip angle (FA) = 12°, data matrix = 256 × 256, field of view (FOV) = 256 × 256 mm^2^, slice thickness = 1 mm, and 136 axial slices covering the whole brain. The R-fMRI data were acquired using a gradient-echo echo-planar imaging (EPI) sequence with the following parameters: TR = 2000 ms, TE = 25 ms, FA = 90°, data matrix = 64 × 64, FOV = 240 × 240 mm^2^, slice thickness = 3 mm with inter-slice gap = 1 mm, 35 interleaved axial slices, and 210 volumes. The subjects were instructed to relax with their eyes closed while remaining awake throughout the scan. The brain structural data were visually checked by two experienced radiologists (Y.W. and Y.S.) to exclude subjects with abnormal brain structure.

2.3. Voxel-based morphometry {#s0025}
----------------------------

All the T1-weighted brain structural images were processed using CAT12 ([http://dbm.neuro.uni-jena.de/cat/](http://dbm.neuro.uni-jena.de/cat){#ir0005}) based on the SPM12 software ([http://www.fil.ion.ucl.ac.uk/spm/software/spm12/](http://www.fil.ion.ucl.ac.uk/spm/software/spm12){#ir0010}), a widely used program for performing voxel-based morphometric (VBM) analyses. For the VBM analysis, we used the diffeomorphic anatomical registration through an exponentiated Lie algebra algorithm (DARTEL) ([@bb0010]) to improve the registration quality of the structural images ([@bb0200]). Briefly, the structural MRI data preprocessing procedures were as follows. First, the original individual T1-weighted images were segmented into gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). Second, the segmented GM and WM images for all the subjects were used to create a study-specific template using DARTEL. Next, the individual segmented images were warped to the study-specific template and spatially normalized to Montreal Neurological Institute (MNI) space using modulation. Finally, the modulated GM images were smoothed with a 6-mm full width at half maximum (FWHM) isotropic Gaussian kernel. Thus, we obtained the smoothed, modulated GM image for each subject.

2.4. Resting-state functional connectivity (RSFC) {#s0030}
-------------------------------------------------

### 2.4.1. R-fMRI data preprocessing {#s0035}

All the original functional images were preprocessed using SPM12 and Data Processing & Analysis for Brain Imaging (DPABI 2.2) ([@bb0390]). The data were processed using the following seven steps. (1) The first 10 functional volumes were discarded for magnetization equilibrium, leaving 200 volumes for further analysis. (2) Slice-timing correction was used to correct the acquisition time delay between slices. (3) Head motion correction was performed using a six-parameter rigid-body transformation. The R-fMRI data from the subjects with excessive head movement (translation \> 2 mm in any plane or rotation \> 2° in any direction) were discarded. In this step, we also estimated the mean framewise displacement (FD) ([@bb0265]) from the derivatives of the six rigid-body realignment parameters. (4) The realigned functional images were spatially normalized to standard MNI space using the DARTEL algorithm. (5) The normalized functional images were sampled to 3 × 3 × 3 mm^3^ and smoothed with a 4-mm FWHM isotropic Gaussian kernel. (6) Temporal band-pass filtering (0.01--0.08 Hz) was performed on the time series for each voxel. (7) A regression model was applied to regress out the nuisance variables (head motion parameters from the Friston 24-parameter model, WM signals, and CSF signals) from the time series of each voxel. The residuals were used in the subsequent resting-state functional connectivity (RSFC) analysis.

### 2.4.2. Seed-based RSFC analysis {#s0040}

The clusters showing significant group difference in GMV (ANOVA test) were selected as the seed regions of interest (ROIs) for the RSFC analysis. First, the peak coordinate for each significant cluster obtained from VBM analysis was determined and was selected to create a 5-mm radius ROI. Next, we extracted the mean time course for each given ROI and calculated its Pearson\'s correlation with the time course of each of the rest voxels in the whole brain to generate the *r*-FC map for each subject. Subsequently, we transformed the individual *r*-FC map into a *z*-FC map using a Fisher *r*-to-*z* transformation to improve the normality for each subject. Finally, we compared the between-group difference in RSFC based on these *z*-FC maps.

2.5. Statistical analysis {#s0045}
-------------------------

### 2.5.1. Demographic and clinical data {#s0050}

A one-way analysis of variance (ANOVA) was used to compare the differences in age and years of education across the MDD, BD, and HC groups. A *χ*^2^-test was conducted to detect group difference in gender. Additionally, two-sample *t*-tests were applied to estimate the differences between the MDD and BD groups in the clinical data, including age of onset, illness duration, number of episodes, HDRS scores, and YMRS scores. The statistical significance level for these analyses was set at *p* \< .05. These statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS).

### 2.5.2. Voxel-based morphometry analysis {#s0055}

A one-way ANOVA, calculated using SPM12, was used to detect differences in the GMV across the MDD, BD, and HC groups with age, gender, years of education, and total intracranial volume (TIV) as covariates. Correction for multiple comparisons was performed using the 3dClustSim program in Analysis of Functional NeuroImages (AFNI, <https://afni.nimh.nih.gov>/), and the cluster threshold was set at an uncorrected voxel-level *p* \< .001, *α* = .05 in these analyses. In this way, we determined the clusters that had significant GMV differences between the three groups.

For each of these clusters, we estimated the relationship between its GMV and the clinical data in the combined BD and MDD group. We first extracted the mean GMV for a given cluster and then calculated the Pearson\'s partial correlation between the GMV value and each of the clinical data measures (age of onset, HDRS scores, illness duration, and number of episodes). In the calculations, we controlled age, gender, and years of education as covariates.

Subsequently, post hoc comparisons were performed to test the GMV differences between each pair of groups based on the significant clusters from the ANOVA analysis. In these calculations, we regressed out the effects of the covariates, which were gender, age, years of education, and TIV, and set the threshold for the multiple comparisons correction to be the same as the one used in the ANOVA analysis.

### 2.5.3. Seed-based RSFC analysis {#s0060}

A one-way ANOVA was performed to study the differences in RSFC values based on the *z*-FC maps across the MDD, BD, and HC groups. After multiple comparisons correction, we obtained the clusters that showed a significant RSFC difference between the three groups. Next, post hoc comparisons were used to determine the difference in RSFC between each pair of groups based on the results of the ANOVA analyses. For the multiple comparisons correction, we used the 3dClustSim program in AFNI and set the cluster threshold at an uncorrected voxel-level *p* \< .001, *α* = .05 in these functional analyses. In these calculations, we controlled age, gender, years of education, and mean framewise displacement (FD) as covariates.

3. Results {#s0065}
==========

3.1. Demographic and clinical comparisons {#s0070}
-----------------------------------------

[Table 1](#t0005){ref-type="table"} lists the demographic and clinical data for all the study subjects. Eight subjects (3 BD and 5 HC) were excluded from the RSFC analysis because of excessive movement during the scanning. Therefore, the final number of subjects in the RSFC study included 40 BD, 36 MDD, and 42 HC. No significant differences were observed in gender distribution (*χ*^2^ = 2.02, *p* = .364), age (*F* = 0.87, *p* = .420), and years of education (*F* = 0.43, *p* = .654) across the MDD, BD, and HC groups. Additionally, no significant differences were found in age of onset (*t* = 1.12, *p* = .265), illness duration (*t* = −0.20, *p* = .846), number of episodes (*t* = −1.67, *p* = .100), HDRS scores (*t* = −0.67, *p* = .505), and YMRS scores (*t* = 0.18, *p* = .861) between the MDD and BD groups.Table 1Demographic and clinical data comparisons.Table 1CharacteristicsMDDBDHCStatistics*p*-valueGender (M/F)20/1617/2622/25*χ*^2^ = 2.02[a](#tf0005){ref-type="table-fn"}.364Age (years old)30.7 (8.5)27.9 (9.1)29.7 (9.2)*F* = 0.87[b](#tf0010){ref-type="table-fn"}.420Education (years)14.1 (3.8)14.3 (2.3)14.7 (3.4)*F* = 0.43[b](#tf0010){ref-type="table-fn"}.654Age of onset (years old)26.8 (8.6)24.3 (10.4)N/A*t* = 1.12[c](#tf0015){ref-type="table-fn"}.265Illness duration (months)32.1 (47.1)34.2 (54.8)N/A*t* = −0.20[c](#tf0015){ref-type="table-fn"}.846Number of episodes1.9 (1.4)2.4 (1.3)N/A*t* = −1.67[c](#tf0015){ref-type="table-fn"}.100HDRS scores28.0 (4.8)28.7 (5.1)N/A*t* = −0.67[c](#tf0015){ref-type="table-fn"}.505YMRS scores2.6 (3.4)2.4 (2.3)N/A*t* = 0.18[c](#tf0015){ref-type="table-fn"}.861[^2][^3][^4][^5]

3.2. VBM analysis {#s0075}
-----------------

### 3.2.1. Comparison of GMV between the three groups {#s0080}

[Fig. 1](#f0005){ref-type="fig"}a shows the clusters with significant differences in GMV between the MDD, BD, and HC groups. We identified four clusters, which were located in the left superior frontal cortex (SFG_L), left anterior cingulate cortex (ACC_L), left thalamus (THA_L), and right hippocampus (HIP_R), that showed significant group differences in GMV. The size and coordinates of these clusters are listed in [Table 2](#t0010){ref-type="table"}. We also compared the mean GMV value of these four significant clusters between the MDD, BD, and healthy controls (Table S2 and Fig. S4).Fig. 1Clusters showing significant differences in gray matter volume (GMV) between the patients with major depressive disorder (MDD), the patients with bipolar disorder (BD), and the healthy controls (HC). (a) Significant clusters obtained from the ANOVA analysis, (b) significant clusters obtained from the post hoc comparisons, and (c) significant correlations between GMV and clinical measures. These clusters were determined using the 3dClustSim correction (uncorrected p \< .001, q \< 0.05). The detected four clusters are located in the right hippocampus (HIP_R, C1), left anterior cingulate cortex (ACC_L, C2), left superior frontal gyrus (SFG_L, C3), and left thalamus (THA_L, C4). The orange clusters indicate positive F or t values, while blue indicates negative values.Fig. 1Table 2Clusters with significant differences in gray matter volume (GMV) between the major depressive disorder (MDD) patients, bipolar disorder (BD) patients, and healthy controls (HC).Table 2Cluster indexRegionsBACluster size (\#voxels)Peak MNI coordinates*F/t*-value*xyz*Three-group comparisonC1HIP_R--16827−12−1211.23[a](#tf0020){ref-type="table-fn"}C2ACC_L32132−2392713.53[a](#tf0020){ref-type="table-fn"}C3SFG_L8, 9352−12264514.28[a](#tf0020){ref-type="table-fn"}C4THA_L--113−18−20012.81[a](#tf0020){ref-type="table-fn"}MDD \< HCC1HIP_R--10227−11−12−4.83[b](#tf0025){ref-type="table-fn"}C2ACC_L32109−34124−7.08[b](#tf0025){ref-type="table-fn"}C3SFG_L8, 9313−122447−6.00[b](#tf0025){ref-type="table-fn"}MDD \> HCC4THA_L--113−18−2004.95[b](#tf0025){ref-type="table-fn"}BD \< HCC1HIP_R--15826−8−17−5.03[b](#tf0025){ref-type="table-fn"}C2ACC_L32108−23927−4.78[b](#tf0025){ref-type="table-fn"}MDD \< BDC2ACC_L32102−34220−4.31[b](#tf0025){ref-type="table-fn"}C3SFG_L8, 9270−92738−4.65[b](#tf0025){ref-type="table-fn"}[^6][^7][^8]

### 3.2.2. Abnormal GMV in MDD patients {#s0085}

In this study, the MDD patients showed significantly decreased GMV in three clusters in the SFG_L, ACC_L, and HIP_R and increased GMV in one cluster in the THA_L compared with the healthy controls ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}).

### 3.2.3. Abnormal GMV in BD patients {#s0090}

We found uniformly significant decreased GMV in two clusters in the ACC_L and HIP_R in the BD patients compared with the healthy controls ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}).

### 3.2.4. GMV differences between MDD and BD patients {#s0095}

The MDD patients showed uniformly significantly decreased GMV in two clusters in the SFG_L and ACC_L compared with the BD patients ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}).

### 3.2.5. Correlations between GMV and clinical characteristics {#s0100}

For each cluster listed in [Table 2](#t0010){ref-type="table"}, we estimated the correlations between its mean GMV value and the clinical variables (age of onset, HDRS scores, illness duration, and number of episodes) in the combined MDD and BD groups. We detected a significantly negative correlation between the GMV of the HIP_R and the number of episodes (*r* = −.35, *p* = .002), and the GMV of the ACC_L was negatively correlated with age of onset (*r* = −.33, *p* = .003). Then we conducted multiple comparisons correction for the number of correlation analyses. Both of these observed significant correlations remained after Bonferroni correction (*p* \< .05).

3.3. Seed-based RSFC analysis {#s0105}
-----------------------------

### 3.3.1. Comparison of RSFC across the three groups {#s0110}

The RSFC of the ACC_L seed with two regions, the left orbital part middle frontal gyrus (ORBmid_L) and left orbital part superior frontal gyrus (ORBsup_L), showed significant differences between the three groups. The RSFC of the SFG_L seed with the HIP_L differed significantly between the three groups. However, we did not detect significant group differences in RSFC when selecting the THA_L or HIP_R as the seed region for functional connectivity. The locations of these seed regions were displayed in Fig. S2.

### 3.3.2. Abnormal RSFC in MDD patients {#s0115}

The RSFC of the ACC_L seed with two areas, the ORBmid_L and ORBsup_L, was significantly decreased in the MDD patients compared with the healthy controls ([Fig. 2](#f0010){ref-type="fig"}a and [Table 3](#t0015){ref-type="table"}). The RSFC of the SFG_L with the cluster in the HIP_L was also decreased in the MDD patients compared with the healthy controls ([Fig. 2](#f0010){ref-type="fig"}b and [Table 3](#t0015){ref-type="table"}).Fig. 2Resting-state functional connectivity (RSFC) seeded from the ACC and SFG in the left hemisphere in either the patients with bipolar disorder (BD) or the patients with major depressive disorder (MDD) compared with the healthy controls (HC). (a) The results for the ACC_L seed region, and (b) the results for the SFG_L seed region. Both the MDD and BD patients showed significantly decreased RSFC between the ACC_L seed and two regions, the ORBsup_L and ORBmid_L. The MDD patients also displayed decreased RSFC between the seed SFG_L and the HIP_L. The negative t value indicates decreased RSFC in the patients compared with the HC. Abbreviations: ACC, anterior cingulate cortex; SFG, superior frontal gyrus; ORBmid, orbital part middle frontal gyrus; ORBsup, orbital part superior frontal gyrus; HIP, hippocampus; L, left hemisphere.Fig. 2Table 3Abnormal resting-state functional connectivity (RSFC) seeded from the left anterior cingulate cortex (ACC_L) and the left superior frontal gyrus (SFG_L) in either the patients with major depressive disorder (MDD) or the patients with bipolar disorder (BD).Table 3SeedClusterBACluster size (\#voxels)Peak MNI coordinates*t-*value*xyz*ACC_LMDD \< HCORBmid_L10, 1127−36513−4.68ORBsup_L10, 1118−1560−6−5.37BD \< HCORBmid_L10, 1141−3054−6−5.17ORBsup_L10, 1126−1260−6−4.60SFG_LMDD \< HCHIP_L--20−30−12−18−5.37[^9]

### 3.3.3. Abnormal RSFC in BD patients {#s0120}

The RSFC of the ACC_L seed with the ORBmid_L and ORBsup_L was significantly decreased in the BD patients compared with the healthy controls ([Fig. 2](#f0010){ref-type="fig"}a and [Table 3](#t0015){ref-type="table"}).

### 3.3.4. RSFC difference between MDD and BD patients {#s0125}

No significant RSFC differences were found between the patients with MDD and those with BD for any given seed ROI.

To validate our results, we also performed the RSFC analysis using the ROIs from both hemispheres. From these analyses, we obtained an FC pattern which is similar to those obtained from the unilateral ROIs. The results were displayed in the Table S1 and Fig. S1.

4. Discussion {#s0130}
=============

In this study, we combined VBM and RSFC approaches to detect abnormal GMV and associated RSFC in patients with MDD and BD. In both the VBM and FC analysis, we detected the altered brain regions in the patients were mainly located in the frontal-limbic network. From the VBM analysis, we found that both the MDD and BD groups showed decreased GMV in the ACC_L and HIP_R and that the MDD patients showed decreased GMV in the SFG_L but increased GMV in the THA_L compared with the healthy controls. Moreover, we found decreased GMV in the ACC_L and SFG_L in the MDD patients compared with the BD patients. Using the clusters derived from the VBM analysis as seed regions, we analyzed the RSFC based on R-fMRI data and found both the MDD and BD groups had decreased RSFC between the ACC_L seed and the left OFC (ORBmid_L, ORBsup_L), and the MDD group showed decreased RSFC between the SFG_L seed and the HIP_L compared with the healthy controls.

4.1. Voxel-based morphometry {#s0135}
----------------------------

### 4.1.1. Common alterations in gray matter volume in MDD and BD {#s0140}

Both the MDD and BD groups showed decreased GMV in the ACC_L compared with the healthy controls ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). The finding of abnormal GMV in the ACC was consistent with previous studies of MDD and BD patients ([@bb0005]; [@bb0380]; [@bb0310]). [@bb0380] compared brain structural differences across BD, MDD, and HC groups and detected significantly decreased GMV in the ACC in both the BD and MDD patient groups compared with the HC group. Thinner cortical thickness (CT) in the ACC was also reported in both MDD ([@bb0365]) and BD patients ([@bb0165]). The ACC has been suggested as being crucial to emotional processing ([@bb0240]; [@bb0275]), especially in evaluating emotional information. [@bb0290] observed abnormal function in the ACC, specifically, decreased activation when responding to happy stimuli and increased activation when responding to sad situations, in BD patients compared with healthy controls. Similarly, [@bb0100] found increased activation in the ACC in MDD patients when responding to anger compared with healthy controls. Taken together, our finding of abnormal GMV of the ACC may be associated with the dysfunction of emotional processing in both BD and MDD patients.

In this study, hippocampal volume loss was also detected in both the MDD and BD groups ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). This finding converges with several previous studies ([@bb0170]; [@bb0305]). Specifically, two recent multi-site large sample analyses ([@bb0170]; [@bb0305]) reported hippocampal atrophy in BD and MDD patients, respectively. As a core region of the limbic system, the hippocampus is essential for cognitive processing, such as learning and memory ([@bb0090]), and plays a key role in the pathologic mechanism of depression ([@bb0320]). One possible explanation for the hippocampal volume loss in MDD and BD patients is that it results from prolonged exposure to stress-induced biochemical abnormalities mediated via the hypothalamic-pituitary-adrenal (HPA) axis ([@bb0320]). Due to a greater number of glucocorticoid receptors in the hippocampus, stress-induced elevated glucocorticoid levels in the patients could result in GMV loss in the hippocampus ([@bb0105]). Moreover, animal study ([@bb0230]) also supported that the decreased volume in the hippocampus may be a critical pathology in depression. The hippocampus loss was induced by abnormal enhancement of glutamate release and dendritic atrophy in rats. Thus, we inferred that structural abnormality of the HIP may be associated with the pathophysiological underpinnings and impaired cognitive function in both MDD and BD patients.

### 4.1.2. Gray matter volume difference between MDD and BD {#s0145}

The MDD patients showed decreased GMV in the ACC_L compared with the BD patients ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). This result is in line with a previous study ([@bb0280]) that found significantly decreased GMV in the ACC_L in an MDD group compared with a BD group and revealed that the ACC showed strong feature weights that contributed to discriminating MDD from BD patients in a classification analysis. Previous studies ([@bb0325]; [@bb0235]) suggested that the ACC is involved in self-referential processing, such as negative self-referential thoughts and rumination. In addition, [@bb0025] reported that MDD patients showed more negative self-referential thoughts and ruminations than BD patients, and [@bb0205] found that the ruminations were correlated negatively with the GMV of the ACC. The greater ACC volume reduction in MDD patients than in BD patients may be associated with this greater amount of rumination.

In this study, we also found decreased GMV in the SFG_L, part of the dorsolateral prefrontal cortex (DLPFC), in the MDD patients compared with the BD patients ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). This finding is consistent with a previous study ([@bb0380]), in which [@bb0380] compared the GMV in either BD patients or MDD patients with that of healthy controls and found decreased GMV compared with HC in the DLPFC only in MDD patients, but not in BD patients. Repetitive transcranial magnetic stimulation (rTMS) to the DLPFC has been reported to be an effective tool to improve symptoms in treatment-resistant MDD patients in clinical ([@bb0050]), but whether it is effective for BD patients is controversial ([@bb0245]). Moreover, [@bb0420] analyzed fALFF based on R-fMRI data and found decreased fALFF in the SFG_L in MDD patients compared with either BD patients or healthy controls. In addition, previous studies reported that the SFG hypoactivation was associated with the severity of rumination ([@bb0300]), and MDD patients showed more negative ruminations than BD patients ([@bb0025]). Taken together, the GMV of the SFG_L are different between MDD and BD patients and the difference may be associated with the ruminations to some extent.

### 4.1.3. Altered gray matter volume only in MDD {#s0150}

We found increased GMV in the left thalamus in the MDD patients compared with the healthy controls ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). Several studies reported altered GMV in the thalamus in MDD patients, either increased ([@bb0425]; [@bb0255]) or decreased ([@bb0080]), compared with healthy controls. [@bb0425] and [@bb0255] found increased GMV in the thalamus in medication-free MDD patients, whereas [@bb0080] detected decreased GMV in the thalamus in a combined group of medicated and non-medicated MDD patients compared with a group of healthy controls. This inconsistency may indicate that medication use influences the direction of GMV changes in the thalamus in MDD patients. The thalamus, a complicated sensory information node, has been reported to be crucial to emotion, memory, and arousal ([@bb0340]). The structural alteration of the thalamus was considered to help account for the deficits in top-down regulation of negative emotions among individuals with MDD patients ([@bb0370]). In addition to structural studies, functional MRI study ([@bb0180]) has reported abnormal thalamus activity in emotional memory processing, and PET and SPECT meta-analysis study ([@bb0155]) revealed that greater activity in the thalamus was correlated with enhanced processing of negative information in MDD patients. In this study, we detected no GMV alteration in the thalamus in the BD patients, which is in line with a previous study ([@bb0195]), that detected decreased thalamus volume in MDD patients but not in BD patients compared with healthy controls. Therefore, our finding of increased GMV of the thalamus may be associated with the medicated-free status of the MDD patients.

The MDD patients also showed decreased GMV in the SFG_L compared with the HC ([Fig. 1](#f0005){ref-type="fig"}b and [Table 2](#t0010){ref-type="table"}). This finding is consistent with several previous studies ([@bb0410]; [@bb0190]; [@bb0255]). Specifically, MDD patients had a decreased GMV in the SFG that was associated with various clinical characteristics, such as first-episode medication-free ([@bb0255]), medicated ([@bb0190]), and remitted MDD patients ([@bb0410]). The SFG was considered to be important to emotional processing ([@bb0115]). [@bb0115] found MDD patients had decreased activation in SFG when responding to emotional stimulus. The degree of SFG hypoactivation would be associated with the severity of rumination in MDD patients ([@bb0300]). In addition, the SFG is a key region for cognitive control ([@bb0065]) and attention processing ([@bb0210]). The GMV loss in SFG would be correlated with the cognitive impairment ([@bb0405]) and attention deficits ([@bb0215]) in MDD patients. [@bb0135] found the GMV deficits in SFG was correlated with the severity of depression in MDD. Moreover, using the amplitude of low-frequency fluctuations (ALFF) method, [@bb0150] found the ALFF in SFG could be used to differentiate the early-onset from late-onset MDD patients, which suggested the SFG may play an important role in the pathology of major depression.

4.2. Resting-state functional connectivity {#s0155}
------------------------------------------

### 4.2.1. Common alterations in RSFC in MDD and BD {#s0160}

In this study, we found that both the MDD and BD patients displayed decreased RSFC within the frontal-cingulate network, mainly between the ACC_L and left orbitofrontal cortex (OFC_L) ([Fig. 1](#f0005){ref-type="fig"}a and [Table 3](#t0015){ref-type="table"}). This finding converges with previous studies ([@bb0085]) in which [@bb0085] found decreased ACC-OFC RSFC in depressed patients compared with healthy controls. The OFC in the frontal-limbic system is known to be involved in emotional processing ([@bb0335]) and decision making ([@bb0185]). In MDD patients, [@bb0120] found that the OFC-cingulate system showed decreased activation, which was related to a failure to regulate positive and negative processing, during a facial emotion matching task. [@bb0185] suggested that MDD patients showed decreased activation in the OFC when responding to risky decisions compared with controls. Additionally, the RSFC of ACC-OFC change could reflect the treatment effect of depression in patients ([@bb0015]). [@bb0015] found that the FC of the ACC-OFC was positively related to a better clinical response during accelerated intermittent theta burst stimulation (aiTBS) treatment and could be used to distinguish aiTBS responders from non-responders. Thus, we suggest that abnormal ACC-OFC connectivity may be associated with dysfunction in emotion processing and decision making in depression and could reflect symptom severity to some extent.

### 4.2.2. Alterations of RSFC only in MDD {#s0165}

We found that the MDD patients displayed decreased RSFC between the SFG_L and the HIP_L compared with the healthy controls ([Fig. 2](#f0010){ref-type="fig"}b and [Table 3](#t0015){ref-type="table"}). This result is compatible with previous studies ([@bb0345]; [@bb0430]). Specifically, [@bb0345] found a reduction in SFG-HIP RSFC in recurrent MDD patients and [@bb0430] found decreased SFG-HIP RSFC in older adults with subthreshold depression compared with healthy subject. The hippocampus is crucial to emotion processing and memory ([@bb0090]), and the SFG, part of the DLPFC, is a key region involved in cognitive control ([@bb0065]). The impaired SFG-HIP RSFC in the MDD supports a cognitive neurobiological model ([@bb0070]) that suggests that functional deficits in the DLPFC may impair top-down control over the limbic areas (e.g., HIP) in depression. Taken together, functional dysconnectivity of the SFG-HIP may be associated with impairment of emotion regulation in MDD patients.

Using VBM and FC analyses, we detected that brain structural and functional alterations in the patients with MDD and BD. The significantly altered regions were mainly located in the frontal-limbic system, which is believed closely relating to the clinical symptoms, such as emotional dysregulation, cognitive impairment, and rumination. These findings were in accordance with recent studies from different modalities ([@bb0270]; [@bb0080]; [@bb0280]; [@bb0255]; [@bb0055]; [@bb0085]; [@bb0420]). Using VBM analysis, [@bb0280] found that both MDD and BD patients had GMV abnormalities in the ACC, HIP, and frontal regions, compared with the healthy group. The GMV alterations in the frontal-limbic system were also reported in structural meta-analyses in MDD patients ([@bb0080]; [@bb0255]). In fMRI studies, [@bb0420] detected MDD had decreased ALFF in the SFG and BD patients had increased ALFF in the putamen, compared with healthy group, and [@bb0085] found decreased ACC-OFC RSFC in MDD patients. Moreover, in diffusion tensor imaging (DTI) studies, [@bb0055] observed decreased fractional anisotropy (FA) in the corpus callosum (CC), anterior limb of the internal capsule (ALIC), and SFG in MDD patients compared with healthy controls. In addition, genetic studies also revealed the frontal-limbic abnormalities in depression ([@bb0270]). Taken together, our findings suggest that the frontal-limbic system may be critical to the pathology of both BD and MDD and need further study in the future.

5. Limitations {#s0170}
==============

The present study has some potential limitations. First, the sample size was relatively small. A larger independent sample is needed to examine the reproducibility of these findings. Second, because about 10--20% of patients initially diagnosed with MDD may eventually turn out to have BD ([@bb0385]), we cannot be certain whether some patients we diagnosed with MDD would turn out to have BD in the future. This may have affected the results. However, none of the MDD patients in our study had a family history of BD. Additionally, we tracked the illness states of the MDD patients in this study and found that none of them had switched to BD before the submission of this manuscript. Third, the subjects included in the VBM and RSFC analysis were not exactly the same. Because of the excessive head motion, eight subjects\' functional data were excluded before the RSFC analysis. We repeated the VBM analysis that discarded these subjects\' structural data and found similar results. Fourth, because this was a cross-sectional study, we cannot determine the causal relationship between the disorders and the brain structural and functional alterations. Longitudinal studies may help to clarify this question.

6. Conclusion {#s0175}
=============

In summary, using a multimodal approach, we detected shared and specific brain abnormalities in BD and MDD patients. The structural and functional results we detected were primarily located in the frontal-limbic network. Compared to the healthy controls, both the BD and MDD patients displayed decreased gray matter volume in the ACC and hippocampus and decreased functional connectivity between the ACC and OFC. We also found decreased gray matter volume in the ACC and SFG in the MDD patients compared with the BD patients. Our results revealed that the MDD and BD patients were more similar than different in gray matter volume and functional connectivity. These findings suggested that the frontal-limbic system might be useful for understanding the underlying mechanisms of affective disorders.
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